by rdbiomed | Aug 22, 2021 | Latest Pepsin Research, Reflux Diagnosis
Peptest is a ‘good screening test’ for medical professionals, such as GPs, allergists, ENT specialists, gastroenterologists and chest physicians, to detect laryngopharyngeal reflux (LPR). In a new study, published in the Journal of Clinical Medicine, Peptest helped... 
by rdbiomed | Jul 9, 2021 | Latest Pepsin Research
A new study has evaluated the phenotypes of gastro-oesophageal reflux disease to demonstrate the relationship between gastric pepsin and gastric pH and that high gastric pepsin concentrations are associated with low gastric pH. Professor Peter Dettmar and Jeanine... 
by rdbiomed | Mar 5, 2021 | Company Updates, Latest Pepsin Research
We’re excited to hear that Peptest has proved valuable in helping identify symptoms of ‘silent reflux’ at NHS respiratory clinics at the Bristol Royal Infirmary. Many people associate reflux with symptoms, such as heartburn or acid reflux, but it can also cause... 
by rdbiomed | Feb 15, 2021 | Latest Pepsin Research, reflux treatments
Measuring salivary pepsin levels has the potential to reduce time to diagnose acid reflux, minimise the use of proton pump inhibitor (PPI) therapy, and streamline care for patients with symptoms. That’s the findings of a new study undertaken at two care centres at the... 
by rdbiomed | Oct 22, 2020 | Latest Pepsin Research
Peptest is a useful, non-invasive diagnostic test for self-diagnosing reflux related symptoms, a study published in the EC Gastroenterology and Digestive System journal has highlighted. Many people suffering from troublesome reflux-related symptoms, such as... 
by rdbiomed | Oct 19, 2020 | Latest Pepsin Research
Salivary pepsin detection is hailed a ‘simpler, more cost-effective and less traumatic universal first-line alternative’ to 24-hour pH monitoring in diagnosing laryngopharyngeal reflux disease (LPR). For the first time, researchers have simultaneously evaluated the...
Recent Comments